By SC inj. Women undergoing superovulation prior to assisted reproductive techniques eg, in vitrofertilisation (IVF) 250 mcg SC 24-48 hr after the last administration of an FSH or hMG prep. Anovulatory or oligo-ovulatory women 250 mcg SC 24-48 hr after optimal follicular growth stimulation is achieved. The patient is recommended to have coitus on the day of & the day after inj.
View Ovidrel overdosage for action to be taken in the event of an overdose.
Contraindications
Hypothalamic & pituitary tumours; ovarian enlargement or cyst due to reasons other than polycystic ovarian disease; gynaecological haemorrhage of unknown aetiology; ovarian, uterine or mammary carcinoma; extrauterine pregnancy in the previous 3 mth; active thromboembolic disorders. Pregnancy & lactation.
Hypothyroidism, adrenocortical deficiency, hyperprolactinemia, pituitary or hypothalamic tumours, clinically significant systemic diseases where pregnancy could exacerbate the condition.
Sign Out
